Downregulation of c-myc protein by siRNA-mediated silencing of DNA-PKcs in HeLa cells

International Journal of Cancer

Volumn 117, Issue 4, 2005, Pages 531-537

  An, Jing ^a   Xu, Qing Zhi ^a   Sui, Jian Li ^a   Bai, Bei ^a   Zhou, Ping Kun ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

c myc; DNA PKcs; Gene expression radiosensitivity; siRNA

Indexed keywords

ALKALINE PHOSPHATASE; COMPLEMENTARY DNA; DNA DEPENDENT PROTEIN KINASE; MESSENGER RNA; MYC PROTEIN; SMALL INTERFERING RNA; WORTMANNIN;

ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DNA DAMAGE; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IONIZING RADIATION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET IRRADIATION; WESTERN BLOTTING;

ANDROSTADIENES; BASE SEQUENCE; BLOTTING, NORTHERN; DNA PRIMERS; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE SILENCING; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING;

EID: 27144472963     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21093     Document Type: Article

References (53)

1. Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002;23:687-96.
2. Park SJ, Oh EJ, Yoo MA, Lee SH. Involvement of DNA-dependent protein kinase in regulation of stress-induced JNK activation. DNA Cell Biol 2001;20:637-45.
3. Brush GS, Anderson CW, Kelly TJ. The DNA-activated protein kinase is required for the phosphorylation of replication protein A during simian virus 40 DNA replication. Proc Natl Acad Sci USA 1994;91:12520-4.
4. Goudelock DM, Jiang K, Pereira E, Russell B, Sanchez Y. Regulatory interactions between the checkpoint kinase Chk1 and the proteins of the DNA-dependent protein kinase complex. J Biol Chem 2003;278:29940-7.
5. Ding Q, Reddy YVR, Wang W, Woods T, Douglas P, Ramsden DA, Lees-Miller SP, Meek K. Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair. Mol Cell Biol 2003;23:5836-48.
6. Bailey SM, Brenneman MA, Halbrook J, Nickoloff JA, Ullrich RL, Goodwin EH. The kinase activity of DNA-PK is required to protect mammalian telomeres. DNA Repair (Amst) 2004;3:225-33.
7. Hande MP. DNA repair factors and telomere-chromosome integrity in mammalian cells. Cytogenet Genome Res 2004;104:116-22.
8. Moll U, Lau R, Sypes MA, Gupta MM, Anderson CW. DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues. Oncogene 1999;18:3114-26.
9. Sakata K, Matsumoto Y, Tauchi H, Satoh M, Oouchi A, Nagakura H, Koito K, Hosoi Y, Suzuki N, Komatsu K, Hareyama M. Expression of genes involved in repair of DNA double-strand breaks in normal and tumor tissues. Int J Radiat Oncol Biol Phys 2001;49:161-7.
10. Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, Morita A, Nagawa H, Suzuki N. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 2004;25:461-8.
11. Nguyen DC, Parsa B, Close A, Magnusson B, Crowe DL, Sinha UK. Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas. Int J Oncol 2003;22:1285-90.
12. Sakata K, Matsumoto Y, Satoh H, Oouchi A, Nagakura H, Koito K, Hosoi Y, Hareyama M, Suzuki N. Clinical studies of immunohistochemical staining of DNA-dependent protein kinase in oropharyngeal and hypopharyngeal carcinomas. Radiat Med 2001;19:93-7.
13. Shintani S, Mihara M, Li C, Nakahara Y, Hino S, Nakashiro K, Hamakawa H. Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma. Cancer Sci 2003;94:894-900.
14. Stronati L, Gensabella G, Lamberti C, Barattini P, Frasca D, Tanzarella C, Giacobini S, Toscano MG, Santacroce C, Danesi DT. Expression and DNA binding activity of the Ku heterodimer in bladder carcinoma. Cancer 2001;92:2484-92.
15. Sui JL, Yu ZJ, Cao ZS, Zhou PZ, Wu DC. Heterogeneous expression of DNA-PK in hepato- and cholangiocellular neoplasms. Toxicology 2003;191:47.
16. Sui JL, Sun JF, Cao ZS, Zhou PK, Wu DC. The abnormal expression of DNA-PKcs in malignant transformed cell line of human bronchial epithelial cells and lung cancers. Chin J Stereol Image Anal 2003;18:141-5.
17. Iijima S, Teraoka H, Date T, Tsukada K. DNA-activated protein kinase in Raji Burkitt's lymphoma cells. Phosphorylation of c-Myc oncoprotein. Eur J Biochem 1992;206:595-603.
18. Karmakar P, Piotrowski J, Brosh RM, Sommers JA, Miller SP, Cheng WH, Snowden CM, Ramsden DA, Bohr VA. Werner protein is a target of DNA-dependent protein kinase in vivo and in vitro, and its catalytic activities are regulated by phosphorylation. J Biol Chem 2002;277:18291-302.
19. Tuteja R, Tuteja N. Ku autoantigen: a multifunctional DNA-binding protein. Crit Rev Biochem Mol Biol 2000;35:1-33.
20. Bonilla M, Ramirez M, Lopez-Cueto J, Gariglio P. In vivo amplification and rearrangement of c-myc oncogene in human breast tumors. J Natl Cancer Inst 1988;80:665-71.
21. Brychtova S, Brychta T, Sedlakova E, Kolar Z. Proto-oncogene c-myc in uterine cervix carcinogenesis. Neoplasma 2004;51:84-9.
22. Erisman MD, Scott JK, Watt RA, Astrin SM. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines. Oncogene 1988;17:367-78.
23. Henriksson M, Luscher B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 1996;68:109-82.
24. Huang E, Ishida S, Pittman J, Dressman H, Bild A, Kloos M, D'Amico M, Pestell GW, West M, Nevins JR. Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet 2003;34:226-30.
25. Smith DR, Myint T, Goh HS. Over-expression of the c-myc protooncogene in colorectal carcinoma. Br J Cancer 1993;68:407-13.
26. Walhout AJ, Gubbels JM, Bernards R, van der Vliet PC, Timmers WT. c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene. Nucleic Acids Res 1997;25:1493-1501.
27. Chibazakura T, Watanabe F, Kitajima S, Tsukada K, Yasukochi Y, Teraoka H. Phosphorylation of human general transcription factors TATA-binding protein and transcription factor UB by DNA-dependent protein kinase-synergistic stimulation of RNA polymerase II basal transcription in vitro. Eur J Biochem 1997;247:1166-73.
28. Jin S, Kharbanda S, Mayer B, Kufe D, Weaver DT. Binding of Ku and c-Abl at the kinase homology region of DNA-dependent protein kinase catalytic subunit. J Biol Chem 1997;272:24763-6.
29. Liu L, Kwak YT, Bex F, Garcia-Martinez LF, Li XH, Meek K, Lane WS, Gaynor RB. DNA-dependent protein kinase phosphorylation of κB α and κB β regulates NF-κB DNA binding properties. Mol Cell Biol 1998;18:4221-34.
30. Komiyama S, Taniguchi S, Matsumoto Y, Tsunoda E, Ohio T, Suzuki Y, Yin HL, Tomita M, Enomoto A, Morita A, Suzuki T, Ohtomo K, et al. Potentiality of DNA-dependent protein kinase to phosphorylate Ser46 of human p53. Biochem Biophys Res Commun 2004;323:816-22.
31. Lee KJ, Jovanovic M, Udayakumar D, Bladen DL, Dynan WS. Identification of DNA-PKcs phosphorylation sites in XRCC4 and effects of mutations at these sites on DNA end joining in a cell-free system. DNA Repair 2004;3:267-76.
32. Wang H, Guan J, Wang H, Perrault AR, Wang Y, Iliakis G. Replication protein A2 phosphorylation after DNA damage by the coordinated action of ataxia telangiectasia-mutated and DNA-dependent protein kinase. Cancer Res 2001;61:8554-63.
33. Um JH, Kwon JK, Kang CD, Kim MJ, Ju DS, Bae JH, Kim DW, Chung BS, Kim SH. Relationship between antiapoptotic molecules and metastatic potency and the involvement of DNA-dependent protein kinase in the chemosensitization of metastatic human cancer cells by epidermal growth factor receptor blockade. J Pharmacol Exp Ther 2004;311:1062-70.
34. Liu LX, Jiang HC, Liu ZH, Zhu AL, Zhou J, Zhang WH, Wang XQ, Wu M. Gene expression profiles of hepatoma cell line BEL-7402. Hepatogastroenterology 2003;50:1496-1501.
35. Oka A, Takashima S, Abe M, Araki R, Takeshita K. Expression of DNA-dependent protein kinase catalytic subunit and Ku80 in developing human brains: implication of DNA-repair in neurogenesis. Neurosci Lett 2000;292:167-70.
36. Sallmyr A, Miller A, Gabdoulkhakova A, Safronova V, Henriksson G, Bredberg A. Expression of DNA-dependent protein kinase in human granulocytes. Cell Res 2004;14:331-40.
37. Nagasawa M, Watanabe F, Suwa A, Yamamoto K, Tsukada K, Teraoka H. Nuclear translocation of the catalytic component of DNA-dependent protein kinase upon growth stimulation in normal human T lymphocytes. Cell Struct Funct 1997;22:585-94.
38. Salminen A, Helenius M, Lahtinen T, Korhonen P, Tapiola T, Soininen H, Solovyan V. Down-regulation of Ku autoantigen, DNA-dependent protein kinase, and poly(ADP-ribose) polymerase during cellular senescence. Biochem Biophys Res Commun 1997;238:712-6.
39. Collis SJ, Swartz MJ, Nelson WG, DeWeese TL. Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. Cancer Res 2003;63:1550-4.
40. Peng Y, Zhang Q, Nagasawa H, Okayasu R, Liber HL, Bedford JS. Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Res 2002;62:6400-4.
41. Kim CH, Park SJ, Lee SH. A targeted inhibition of DNA-pependent protein kinase sensitizes breast cancer cells following ionizing radiation. J Pharmacol Exp Ther 2003;303:753-9.
42. Claassen GF, Hann SR. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta - induced cell-cycle arrest. Proc Natl Acad Sci USA 2000;97:9498-9503.
43. Baudino TA, Maclean KH, Brennan J, Parganas E, Yang C, Aslanian A, Lees JA, Sherr CJ, Roussel MF, Cleveland JL. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Mol Cell 2003;11:905-14.
44. Grandori C, Cowley SM, James LP, Eisenman RN. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000;16:653-99.
45. Flores ID, Murphy J, Swigart LB, Knies U, Evan GL. Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasia. Oncogene 2004;23:5923-30.
46. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-12.
47. Wang J, Xie LY, Allan S, Beach D, Hannon GJ. Myc activates telomerase. Genes Dev 1998;12:1769-74.
48. Frederick JP, Liberati NT, Waddell DS, Shi Y, Wang XF. Transforming growth factor-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol Cel Biol 2004;24:2546-59.
49. Pelengaris S, Khan M. The c-myc oncoprotein as a treatment target in cancer and other disorders of cell growth. Expert Opin Ther Targets 2003;7:623-42.
50. Yagi K, Furuhashi M, Aoki H, Goto D, Kuwano H, Sugamura K, Miyazono K, Kato M. c-myc is a downstream target of the Smad pathway. J Biol Chem 2002;277:854-61.
51. Chen S, Wang G, Makrigiorgos GM, Price BD. Stable siRNA-mediated silencing of ATM alters the transcriptional profile of HeLa cells. Biochem Biophys Res Commun 2004;317:1037-44.
52. Lindstrom MS, Wiman KG. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts. Oncogene 2003;22:4993-5005.
53. Li Y, Wu D, Chen B, Ingram A, He L, Liu L, Zhu D, Kapoor A, Tang D. ATM activity contributes to the tumor-suppressing functions of p14ARF. Oncogene 2004;23:7355-65.